CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shouyao Holdings Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shouyao Holdings Co Ltd
Block 15
Yuquan Huigu Science and Technology Park
Phone: +86 1088857906p:+86 1088857906 BEIJING, BEJ  100195  China Ticker: 688197688197
Business Summary
Shouyao Holdings Co Ltd is a China-based company mainly engaged in the discovery and development of innovative small molecule therapies in the field of cancer. The Company's independently developed product pipeline mainly includes SY-707, SY-3505, SY-5007, SY-5933, SY-4798, SY-4835, SY-9453, SY-7166, SY-12321, and SY-14556. The company's collaborative developed product pipeline mainly includes CT-1139/TQ-B3139, CT-1995/TQ05105, CT-2755/TQ-B3454, CT-034/TQ-B3234, CT-2426/TQ-B3455, CT-133/CSPCHA115, CT-1495/TQ-B3395, CT-1803/TQ-B3303, CT-3417/TQ-B3558, CT-3872/TQ-B3811 and CT-4460/TQ-B3617. The Company operates its businesses in the domestic market.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager WenjunLi 55 1/1/2021 4/1/2016
Chief Financial Officer YajieWang 52 8/1/2020 6/1/2017
Deputy General Manager XijieLiu 47 8/1/2020 4/1/2016
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 172 (As of 12/31/2025)
Outstanding Shares: 148,719,343 (As of 3/31/2026)
Shareholders: 5,008
Stock Exchange: SHA
Fax Number: +86 1088853760


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, May 18, 2026